Eligibility Atrial Fibrillation NCT00622102

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
21 years old age or older
Beskrivning

Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
on warfarin managed at the ac clinic
Beskrivning

on warfarin

Datatyp

boolean

Alias
UMLS CUI [1]
C0851145
target inr 2.0-3.0 or 2.5-3.5
Beskrivning

Target international normalized ratio

Datatyp

boolean

Alias
UMLS CUI [1]
C1272307
at maintenance phase of therapy (defined as stable inr with stable warfarin dosing over at least 2 consecutive visits)
Beskrivning

Therapeutic procedure Maintenance Phase | INR Stable | Warfarin Dosage Stable

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0024501
UMLS CUI [1,3]
C0205390
UMLS CUI [2,1]
C0525032
UMLS CUI [2,2]
C0205360
UMLS CUI [3,1]
C0043031
UMLS CUI [3,2]
C0178602
UMLS CUI [3,3]
C0205360
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
do not have access to telephone line
Beskrivning

Access to telephone Lacking

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1822200
UMLS CUI [1,2]
C0332268
unwillingness to participate or to sign a consent form(refusal)
Beskrivning

Study Subject Participation Status Unwilling | Informed Consent Refused

Datatyp

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C0558080
UMLS CUI [2,1]
C0021430
UMLS CUI [2,2]
C1705116
inability to participate because of advances dementia, advanced alzheimer's disease or other impairment affecting ability to provide informed consent and/or quality data or utilize the med-emonitor
Beskrivning

Study Subject Participation Status Unable | Dementia Advanced | Alzheimer's Disease Advanced | Impairment Affecting Informed Consent | Impairment Affecting Data Quality | Impairment Affecting Medical care

Datatyp

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C1299582
UMLS CUI [2,1]
C0497327
UMLS CUI [2,2]
C0205179
UMLS CUI [3,1]
C0002395
UMLS CUI [3,2]
C0205179
UMLS CUI [4,1]
C0221099
UMLS CUI [4,2]
C0392760
UMLS CUI [4,3]
C0021430
UMLS CUI [5,1]
C0221099
UMLS CUI [5,2]
C0392760
UMLS CUI [5,3]
C0242483
UMLS CUI [6,1]
C0221099
UMLS CUI [6,2]
C0392760
UMLS CUI [6,3]
C0496675
participation in a current study that does not permit participation in another study
Beskrivning

Study Subject Participation Status Illicit

Datatyp

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C0332266
end stage or terminal illness with anticipated life expectancy of 6 months or less
Beskrivning

Terminal illness | Life Expectancy

Datatyp

boolean

Alias
UMLS CUI [1]
C0679247
UMLS CUI [2]
C0023671
inr over the upper limit for the individual's range at the time of enrollment (e.g.,>3.0 or >3.5, depending on the target range)
Beskrivning

INR raised

Datatyp

boolean

Alias
UMLS CUI [1]
C0853225
diagnosed with antiphospholipid antibody syndrome or abnormal inr prior to starting warfarin
Beskrivning

Antiphospholipid Syndrome | INR abnormal

Datatyp

boolean

Alias
UMLS CUI [1]
C0085278
UMLS CUI [2]
C0580417

Similar models

Eligibility Atrial Fibrillation NCT00622102

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
21 years old age or older
boolean
C0001779 (UMLS CUI [1])
on warfarin
Item
on warfarin managed at the ac clinic
boolean
C0851145 (UMLS CUI [1])
Target international normalized ratio
Item
target inr 2.0-3.0 or 2.5-3.5
boolean
C1272307 (UMLS CUI [1])
Therapeutic procedure Maintenance Phase | INR Stable | Warfarin Dosage Stable
Item
at maintenance phase of therapy (defined as stable inr with stable warfarin dosing over at least 2 consecutive visits)
boolean
C0087111 (UMLS CUI [1,1])
C0024501 (UMLS CUI [1,2])
C0205390 (UMLS CUI [1,3])
C0525032 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
C0043031 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0205360 (UMLS CUI [3,3])
Item Group
C0680251 (UMLS CUI)
Access to telephone Lacking
Item
do not have access to telephone line
boolean
C1822200 (UMLS CUI [1,1])
C0332268 (UMLS CUI [1,2])
Study Subject Participation Status Unwilling | Informed Consent Refused
Item
unwillingness to participate or to sign a consent form(refusal)
boolean
C2348568 (UMLS CUI [1,1])
C0558080 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2,1])
C1705116 (UMLS CUI [2,2])
Study Subject Participation Status Unable | Dementia Advanced | Alzheimer's Disease Advanced | Impairment Affecting Informed Consent | Impairment Affecting Data Quality | Impairment Affecting Medical care
Item
inability to participate because of advances dementia, advanced alzheimer's disease or other impairment affecting ability to provide informed consent and/or quality data or utilize the med-emonitor
boolean
C2348568 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C0497327 (UMLS CUI [2,1])
C0205179 (UMLS CUI [2,2])
C0002395 (UMLS CUI [3,1])
C0205179 (UMLS CUI [3,2])
C0221099 (UMLS CUI [4,1])
C0392760 (UMLS CUI [4,2])
C0021430 (UMLS CUI [4,3])
C0221099 (UMLS CUI [5,1])
C0392760 (UMLS CUI [5,2])
C0242483 (UMLS CUI [5,3])
C0221099 (UMLS CUI [6,1])
C0392760 (UMLS CUI [6,2])
C0496675 (UMLS CUI [6,3])
Study Subject Participation Status Illicit
Item
participation in a current study that does not permit participation in another study
boolean
C2348568 (UMLS CUI [1,1])
C0332266 (UMLS CUI [1,2])
Terminal illness | Life Expectancy
Item
end stage or terminal illness with anticipated life expectancy of 6 months or less
boolean
C0679247 (UMLS CUI [1])
C0023671 (UMLS CUI [2])
INR raised
Item
inr over the upper limit for the individual's range at the time of enrollment (e.g.,>3.0 or >3.5, depending on the target range)
boolean
C0853225 (UMLS CUI [1])
Antiphospholipid Syndrome | INR abnormal
Item
diagnosed with antiphospholipid antibody syndrome or abnormal inr prior to starting warfarin
boolean
C0085278 (UMLS CUI [1])
C0580417 (UMLS CUI [2])